ENG: Researchers at UCL’s Sainsbury Wellcome Centre have uncovered how sensory inputs are transformed into motor actions, revealing that decision-making is a global process across the brain, rather than being confined to individual regions. This groundbreaking study utilized Neuropixels probes to record neural activity across multiple brain regions in mice, offering insights into how learning drives the brain’s ability to process and act on sensory information.
ENG: Researchers at UC Riverside have developed a groundbreaking air-powered computer that enhances the reliability and reduces the cost of Intermittent Pneumatic Compression (IPC) devices, which are used to prevent blood clots and strokes by improving blood circulation. Unlike traditional IPC devices that rely on electronic sensors, this new invention uses compressed air to monitor the device’s performance and alert medical staff to any malfunctions by blowing a whistle when an issue is detected. This air-powered system not only eliminates the need for costly electronics but also operates efficiently in environments where high humidity or temperature could compromise electronic components.
ENG: Engineers at the University of California, San Diego have pioneered a groundbreaking medical technology involving microrobots capable of delivering cancer-fighting drugs directly to tumors in the lungs. These microscopic robots, which combine elements of biology and nanotechnology, have been successfully tested in mice to target metastatic tumors. The use of these microrobots has significantly inhibited tumor growth and spread, leading to increased survival rates in test subjects. This innovation represents a significant advancement in the treatment of metastatic cancer, particularly in its ability to deliver therapeutics efficiently to hard-to-reach areas of the lung.
ENG: In a significant advancement for gene therapy targeting brain diseases, scientists at the Broad Institute of MIT and Harvard have developed a novel gene-delivery vehicle. This vehicle is designed to efficiently transport therapeutic genes across the blood-brain barrier—a critical obstacle in treating neurological conditions. The researchers utilized a human protein to facilitate this process, enabling the delivery of a disease-relevant gene to the brain in mice. Their successful approach, which capitalizes on the human transferrin receptor highly expressed in the blood-brain barrier, presents a promising potential for application in human patients.
